Chi Cheng Wang
Chairman bij Weihai Pu Lewei Medical Device Co. Ltd.
Profiel
Chi Cheng Wang was the founder of JW Medical Systems Ltd.
(founded in 2003) and HeMo (China) Bioengineering Co., Ltd.
(founded in 2016), where he held the titles of Chief Executive Officer and Chairman, Chief Executive & Technology Officer, respectively.
Currently, he holds multiple positions, including Chairman at Weihai Pu Lewei Medical Device Co. Ltd.
(since 2017), Director at Max Vision Corp.
Ltd.
(since 2017), Executive Director at Weihai HeMo Jirui Biological Technology Ltd.
(since 2020), Director at HeMo (China) Bioengineering Ltd.
(since 2016), and Director at HeMo Bioengineering Pte Ltd.
(since 2020).
He also held the position of Chief Technology Officer at Biosensors International Group Ltd.
from 2014 to 2015.
Dr. Wang received a doctorate degree from Case Western Reserve University in 1994, a graduate degree from Clarkson University, and an undergraduate degree from Tsinghua University in 1982.
Actieve functies van Chi Cheng Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| Max Vision Corp. Ltd. | Director/Board Member | 01-07-2017 |
| Weihai HeMo Jirui Biological Technology Ltd. | Director/Board Member | 01-05-2020 |
| HeMo (China) Bioengineering Ltd. | Director/Board Member | 01-04-2016 |
HeMo Bioengineering Pte Ltd.
 HeMo Bioengineering Pte Ltd. Medical SpecialtiesHealth Technology HeMo Bioengineering Pte Ltd. develops neurovascular interventional devices for treating stroke patients. The private company is based in Singapore, Singapore. and has subsidiaries in Singapore. | Director/Board Member | 01-11-2020 |
| Weihai Pu Lewei Medical Device Co. Ltd. | Chairman | 01-08-2017 |
Eerdere bekende functies van Chi Cheng Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOSENSORS INTERNATIONAL GROUP LTD | Chief Executive Officer | 01-09-2014 |
HeMo (China) Bioengineering Co., Ltd.
 HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Chief Executive Officer | - |
JW Medical Systems Ltd.
 JW Medical Systems Ltd. Medical SpecialtiesHealth Technology JW Medical Systems Ltd. develops and distributes drug-eluting stent technology. The joint venture company is based in Weihai, China. The Chinese company was founded by Chi Cheng Wang. The CEO is Simon Li. | Chief Executive Officer | - |
Opleiding van Chi Cheng Wang
| Case Western Reserve University | Doctorate Degree |
| Clarkson University | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
JW Medical Systems Ltd.
JW Medical Systems Ltd. Medical SpecialtiesHealth Technology JW Medical Systems Ltd. develops and distributes drug-eluting stent technology. The joint venture company is based in Weihai, China. The Chinese company was founded by Chi Cheng Wang. The CEO is Simon Li. | Health Technology |
HeMo (China) Bioengineering Co., Ltd.
HeMo (China) Bioengineering Co., Ltd. Information Technology ServicesTechnology Services HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China. | Technology Services |
| Max Vision Corp. Ltd. | |
| Weihai HeMo Jirui Biological Technology Ltd. | |
| HeMo (China) Bioengineering Ltd. | |
HeMo Bioengineering Pte Ltd.
HeMo Bioengineering Pte Ltd. Medical SpecialtiesHealth Technology HeMo Bioengineering Pte Ltd. develops neurovascular interventional devices for treating stroke patients. The private company is based in Singapore, Singapore. and has subsidiaries in Singapore. | Health Technology |
| Weihai Pu Lewei Medical Device Co. Ltd. |
